This combination also demonstrated the ability to improve glucose metabolism in vivo in 2 type 2 diabetes mouse models: nonfasting serum glucose significantly decreased in KK-Ay/Ta mice and non-fasting serum insulin significantly decreased in db/db mice after administration with RIAA : PAC at 1 : 5. The gene discussed is INS; the disease is type 2 diabetes mellitus.